Results

Celcuity Inc.

04/08/2021 | Press release | Distributed by Public on 04/08/2021 14:08

Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides[...]